Delusional Misidentification in Association With Parkinsonism

The delusional misidentification syndrome (DMS) has been associated with a range of neurological conditions. Three cases of DMS in patients with Parkinson's disease and dementia, treated with dopaminergic medications, are presented. It is postulated that DMS associated with parkinsonism results...

Full description

Saved in:
Bibliographic Details
Published in:The journal of neuropsychiatry and clinical neurosciences 1998, Vol.10 (2), p.194-198
Main Authors: Roane, David M, Rogers, John D, Robinson, Jessica H, Feinberg, Todd E
Format: Article
Language:English
Subjects:
Aged
Antiparkinson Agents - adverse effects
Antipsychotic Agents - therapeutic use
Capgras Syndrome - chemically induced
Capgras Syndrome - complications
Capgras Syndrome - drug therapy
Clozapine - therapeutic use
Delusions - chemically induced
Delusions - complications
Delusions - drug therapy
Female
Hallucinations - chemically induced
Hallucinations - complications
Hallucinations - drug therapy
Humans
Male
Parkinson Disease - complications
Parkinson Disease - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The delusional misidentification syndrome (DMS) has been associated with a range of neurological conditions. Three cases of DMS in patients with Parkinson's disease and dementia, treated with dopaminergic medications, are presented. It is postulated that DMS associated with parkinsonism results from a combination of dopaminergic psychosis and cognitive dysfunction involving the frontal lobe in particular. DMS in the setting of parkinsonism may be more frequent than commonly supposed.
ISSN:0895-0172
1545-7222
DOI:10.1176/jnp.10.2.194